NO20003315L - Indol-derivater anvendelige bl a for behandling av osteoporose - Google Patents

Indol-derivater anvendelige bl a for behandling av osteoporose

Info

Publication number
NO20003315L
NO20003315L NO20003315A NO20003315A NO20003315L NO 20003315 L NO20003315 L NO 20003315L NO 20003315 A NO20003315 A NO 20003315A NO 20003315 A NO20003315 A NO 20003315A NO 20003315 L NO20003315 L NO 20003315L
Authority
NO
Norway
Prior art keywords
osteoporosis
treatment
inter alia
indole derivatives
derivatives useful
Prior art date
Application number
NO20003315A
Other languages
English (en)
Other versions
NO20003315D0 (no
NO320272B1 (no
Inventor
Stefania Gagliardi
Pietro Novella
Guy Marguerite Marie Ge Nadler
Original Assignee
Smithkline Beecham Lab
Smithkline Beecham Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Lab, Smithkline Beecham Spa filed Critical Smithkline Beecham Lab
Publication of NO20003315D0 publication Critical patent/NO20003315D0/no
Publication of NO20003315L publication Critical patent/NO20003315L/no
Publication of NO320272B1 publication Critical patent/NO320272B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20003315A 1997-12-24 2000-06-23 Indolderivater, deres fremstilling og formulering i farmasoytiske preparater anvendbare for behandling av osteoporose og beslektede sykdommer NO320272B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97403154 1997-12-24
PCT/EP1998/008561 WO1999033822A1 (en) 1997-12-24 1998-12-17 Indole derivatives useful a.o. for the treatment of osteoporosis

Publications (3)

Publication Number Publication Date
NO20003315D0 NO20003315D0 (no) 2000-06-23
NO20003315L true NO20003315L (no) 2000-06-23
NO320272B1 NO320272B1 (no) 2005-11-14

Family

ID=8229937

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003315A NO320272B1 (no) 1997-12-24 2000-06-23 Indolderivater, deres fremstilling og formulering i farmasoytiske preparater anvendbare for behandling av osteoporose og beslektede sykdommer

Country Status (22)

Country Link
EP (1) EP1042316B1 (no)
JP (1) JP4627881B2 (no)
KR (1) KR20010033528A (no)
CN (1) CN1208333C (no)
AR (1) AR018032A1 (no)
AT (1) ATE288909T1 (no)
AU (1) AU749319B2 (no)
BR (1) BR9814403A (no)
CA (1) CA2315723A1 (no)
CO (1) CO4970811A1 (no)
DE (1) DE69828998T2 (no)
ES (1) ES2236971T3 (no)
HU (1) HUP0100785A3 (no)
IL (1) IL136720A0 (no)
NO (1) NO320272B1 (no)
NZ (1) NZ505060A (no)
PL (1) PL191633B1 (no)
SA (1) SA99200109B1 (no)
SI (1) SI1042316T1 (no)
TR (1) TR200001992T2 (no)
WO (1) WO1999033822A1 (no)
ZA (1) ZA9811758B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914371D0 (en) 1999-06-18 1999-08-18 Smithkline Beecham Plc Novel compounds
GB9914825D0 (en) 1999-06-24 1999-08-25 Smithkline Beecham Spa Novel compounds
AU2001249679A1 (en) 2000-03-31 2001-10-15 Ortho-Mcneil Pharmaceutical, Inc. Phenyl-substituted imidazopyridines
ATE430730T1 (de) * 2000-03-31 2009-05-15 Ortho Mcneil Pharm Inc Phenyl-substituierte indole als h3 histaminrezeptorantagonisten
US6872834B2 (en) 2000-03-31 2005-03-29 Ortho-Mcneil Pharmaceutical, Inc. Phenyl-substituted indoles and indazoles
ITMI20040875A1 (it) * 2004-04-30 2004-07-30 Ist Naz Stud Cura Dei Tumori Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali
US20090142832A1 (en) * 2007-11-29 2009-06-04 James Dalton Indoles, Derivatives, and Analogs Thereof and Uses Therefor
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
RU2741576C2 (ru) * 2014-10-24 2021-01-27 Лэндос Байофарма, Инк. Лекарственные средства на основе лантионинсинтетаза c-подобного белка 2
US11197891B2 (en) 2017-11-30 2021-12-14 Landos Biopharma, Inc. Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
AU2020407645B2 (en) 2019-12-20 2022-10-06 Nimmune Biopharma, Inc. Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3542827B2 (ja) * 1994-07-15 2004-07-14 帝国臓器製薬株式会社 新規な5−置換イソキサゾール−3−カルボン酸アミド誘導体
JPH10512251A (ja) * 1995-01-10 1998-11-24 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ 骨粗鬆症の治療に有用なインドール誘導体
AU757059B2 (en) * 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto

Also Published As

Publication number Publication date
JP2003532616A (ja) 2003-11-05
SI1042316T1 (no) 2005-08-31
CO4970811A1 (es) 2000-11-07
ATE288909T1 (de) 2005-02-15
CN1208333C (zh) 2005-06-29
ZA9811758B (en) 2000-06-22
HK1032953A1 (en) 2001-08-10
EP1042316B1 (en) 2005-02-09
AU749319B2 (en) 2002-06-20
CA2315723A1 (en) 1999-07-08
BR9814403A (pt) 2000-10-10
HUP0100785A2 (hu) 2001-08-28
NZ505060A (en) 2002-09-27
KR20010033528A (ko) 2001-04-25
EP1042316A1 (en) 2000-10-11
DE69828998D1 (de) 2005-03-17
DE69828998T2 (de) 2006-05-04
PL341318A1 (en) 2001-04-09
NO20003315D0 (no) 2000-06-23
AR018032A1 (es) 2001-10-31
IL136720A0 (en) 2001-06-14
WO1999033822A1 (en) 1999-07-08
AU2715499A (en) 1999-07-19
CN1299357A (zh) 2001-06-13
ES2236971T3 (es) 2005-07-16
PL191633B1 (pl) 2006-06-30
NO320272B1 (no) 2005-11-14
JP4627881B2 (ja) 2011-02-09
HUP0100785A3 (en) 2001-09-28
TR200001992T2 (tr) 2001-01-22
SA99200109B1 (ar) 2006-09-13

Similar Documents

Publication Publication Date Title
NO986052D0 (no) Antikonvulsive derivater for behandling av fedme
BR9612465A (pt) Compostos heterocíclicos
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
FI102425B1 (fi) Menetelmä muistin toteuttamiseksi
FI972919A0 (fi) Indolijohdannaisia jotka ovat käyttökelpoisia osteoporoosin hoidossa
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
NO982462L (no) Maling av fyllingsgrad
NO20003315D0 (no) Indol-derivater anvendelige bl a for behandling av osteoporose
ATA100695A (de) Prothrombin-derivate
NO20002174L (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO20001387D0 (no) Fremgangsmåte for syntese av kinolinderivater
DK0975594T3 (da) Fremgangsmåde til fremstilling af indolderivater
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO20062796L (no) Fremgangsmate for fremstilling av en dihydroksyaminoforbindelse
ATE202093T1 (de) 4-amino-benzoylguanidin-derivate
ATE177102T1 (de) Chromanderivate
ATE193701T1 (de) Substituierte indol-derivate
NO993549L (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO995750D0 (no) Fremgangsmåte til fremstilling av et deoksyuridinderivat
ATE202088T1 (de) 4-mercapto-benzoylguanidin-derivate
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
ATA45796A (de) Lysin-prolin-derivate
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler